Alerus Financial Na adds Zimmer Biomet Holdings Inc (ZBH) to its portfolio

Zimmer Biomet Holdings Inc (ZBH) : Alerus Financial Na added new position in Zimmer Biomet Holdings Inc during the most recent quarter end. The investment management firm now holds 36,748 shares of Zimmer Biomet Holdings Inc which is valued at $4,752,986 , the company said in a statement filed on Aug 11, 2016 with the SEC.Zimmer Biomet Holdings Inc makes up approximately 0.77% of Alerus Financial Na’s portfolio.

Other Hedge Funds, Including , Fic Capital Inc added ZBH to its portfolio by purchasing 1,740 company shares during the most recent quarter which is valued at $225,052. Zimmer Biomet Holdings Inc makes up approx 0.10% of Fic Capital Inc’s portfolio.Her Majesty The Queen In Right Of The Province Of Alberta… boosted its stake in ZBH in the latest quarter, The investment management firm added 38,700 additional shares and now holds a total of 52,500 shares of Zimmer Biomet Holdings Inc which is valued at $6,847,575. Zimmer Biomet Holdings Inc makes up approx 0.09% of Her Majesty The Queen In Right Of The Province Of Alberta…’s portfolio.Public Employees Retirement Association Of Colorado boosted its stake in ZBH in the latest quarter, The investment management firm added 463 additional shares and now holds a total of 37,826 shares of Zimmer Biomet Holdings Inc which is valued at $4,960,502. Zimmer Biomet Holdings Inc makes up approx 0.04% of Public Employees Retirement Association Of Colorado’s portfolio.

Zimmer Biomet Holdings Inc opened for trading at $128.69 and hit $129.9 on the upside on Tuesday, eventually ending the session at $129.77, with a gain of 1.18% or 1.51 points. The heightened volatility saw the trading volume jump to 12,02,913 shares. Company has a market cap of $25,956 M.

On the company’s financial health, Zimmer Biomet Holdings Inc reported $2.02 EPS for the quarter, beating the analyst consensus estimate by $ 0.05 according to the earnings call on Jul 28, 2016. Analyst had a consensus of $1.97. The company had revenue of $1934.00 million for the quarter, compared to analysts expectations of $1898.18 million. The company’s revenue was up 65.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.58 EPS.

Many Wall Street Analysts have commented on Zimmer Biomet Holdings Inc. SunTrust Initiated Zimmer Biomet Holdings Inc on Aug 11, 2016 to “Buy”, Price Target of the shares are set at $155.Company shares were Reiterated by Needham on Jul 29, 2016 to “Buy”, Firm has raised the Price Target to $ 150 from a previous price target of $143 .Company shares were Reiterated by Needham on Jul 18, 2016 to “Buy”, Firm has raised the Price Target to $ 143 from a previous price target of $134 .

Zimmer Biomet Holdings Inc. formerly Zimmer Holdings Inc. is a musculoskeletal healthcare company. The Company designs manufactures and markets orthopedic reconstructive products; sports medicine biologics extremities and trauma products; spine bone healing craniomaxillofacial and thoracic products; dental implants and related surgical products. The Company manages its operations through three geographic segments: the Americas comprising principally of the United States and includes other North Central and South American markets; Europe comprising principally of Europe and includes the Middle East and African markets; and Asia Pacific comprising primarily of Japan and includes other Asian and Pacific markets. The Company markets and sells products through three channels: direct to healthcare institutions such as hospitals or direct channel accounts; through stocking distributors and healthcare dealers and directly to dental practices and dental laboratories.

Leave a Reply

Zimmer Biomet Holdings Inc - Is it time to Sell?

Top Brokerage Firms are advising their investors on Zimmer Biomet Holdings Inc. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.